Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Ondero Met-OD 1 gm Tablet ER

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Metformin (1000mg) + Linagliptin (5mg)

Overview Ondero Met-OD 1 gm Tablet ER

Diabetics with type 2 mellitus may find relief from elevated blood glucose levels with GlucoDual XR 1g Extended-Release Tablets. This dual-action formulation helps mitigate severe diabetic complications, such as vision impairment and renal dysfunction, and may lessen the risk of cardiovascular events like stroke or myocardial infarction. GlucoDual XR 1g ER Tablets can be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved when coupled with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic readings, and current medications. Consuming the medication with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar management through this treatment contributes to preventing future complications. Adherence to the prescribed diet and exercise plan is crucial. Lifestyle choices play a significant role in diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal distress, headache, nasal congestion, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used concurrently with insulin or sulfonylureas; therefore, understanding hypoglycemia recognition and management is essential. This medication isn't suitable for all individuals. Prior to commencement, inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its potential to reduce blood glucose. Your physician will monitor renal function and blood glucose levels throughout the treatment period.

Uses of Ondero Met-OD 1 gm Tablet ER

Managing type 2 diabetes

Major Benefits of Ondero Met-OD 1 gm Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Ondero Met-OD 1 gm Extended-Release Tablet should be taken with a meal.

Common Side effects of Ondero Met-OD 1 gm Tablet ER:

  • Nausea
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness

How to use Ondero Met-OD 1 gm Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. The Ondero Met-OD 1 gm Extended-Release Tablet should be administered with a meal.

How Ondero Met-OD 1 gm Tablet ER works:

Extended-release Ondero Met-OD tablets (1 gram) contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Ondero Met-OD 1 gm Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Ondero Met-OD 1-gram tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingUNSAFE

Extended-release Ondero Met-OD 1-gram tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Extended-release Ondero Met-OD 1 gram tablets are contraindicated for individuals with renal impairment and should be omitted. Seek medical advice.

LiverLiverUNSAFE

Extended-release Ondero Met-OD 1-gram tablets may pose significant risks for individuals with hepatic impairment and are best avoided. A physician's consultation is recommended.

What if you forget to take Ondero Met-OD 1 gm Tablet ER :

Should you forget a dose of Ondero Met-OD 1 gm Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Ondero Met-OD 1 gm Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Ondero Met-OD 1 gm Tablet ER

Ondero Met-OD 1 gm Tablet ER can cause lactic acidosis (MALA—Metformin-associated lactic acidosis), a rare but serious side effect characterized by excessive blood lactic acid. This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol consumers, hence its avoidance in these groups. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Ondero Met-OD 1 gm Tablet ER and seek immediate medical attention.
Ondero Met-OD 1 gm Tablet ER may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rarely, but seriously, lactic acidosis may occur. Prolonged use may also result in vitamin B12 deficiency.
Ondero Met-OD 1 gm Tablet ER is contraindicated in patients with allergies to its components, severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis. Consult your doctor before use.
Combining Ondero Met-OD 1 gm Tablet ER and alcohol is unsafe and may heighten the risk of lactic acidosis, especially if you're fasting, malnourished, or have kidney problems. Consult your doctor if you have any concerns.
Store this medication in its original, tightly sealed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Ondero Met-OD 1 gm Tablet ER rarely causes hypoglycemia by itself; however, insufficient caloric intake while using it can lead to low blood sugar. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting glucose source, such as glucose tablets, honey, or fruit juice.
Prolonged use of Ondero Met-OD 1 gm Tablet ER can interfere with vitamin B12 absorption, potentially leading to deficiency. Untreated deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. If you experience these symptoms, consult your doctor for B12 level monitoring and potential supplementation.
Ondero Met-OD 1 gm Tablet...
139
MRP 161
13% off